Daily as of 3 Nov 16:00 ET
- Price
- above both $178.27 vs 50 $177.82 / 200 $144.90
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 12 Aug 2026 · projected 14 bars out
RGEN | RepligenNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$178.27
+$5.32 (+3.08%)
Repligen (RGEN) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat above the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $176.94 vs 50 $147.42 / 200 $152.04
- Projection
- 🟨Golden cross projected in 11 bars
- Test
- No active test
- Last cross
- 💀Death cross week of 7 Aug 2023 · projected 19 bars out · tested 4 bars
4-hour as of 3 Nov 13:30 ET
- Price
- above both $179.84 vs 50 $178.59 / 200 $162.67
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 24 Jun 2026 · projected 25 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 12 Aug 2026 | 🟨Golden steep | daily | 14 bars out | Not tested |
| 24 Jun 2026 | 🟨Golden | 4-hour | 25 bars out | Not tested |
| 25 Mar 2026 | 💀Death steep | daily | 30 bars out | Not tested |
| 17 Feb 2026 | 💀Death | 4-hour | 27 bars out | Not tested |
| 31 Oct 2025 | 🟨Golden steep | daily | 28 bars out | Not tested |
About RGEN
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$190M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmid